1. Gene Therapy for Restenosis

   • Juha Rutanen
   • Johanna Markkanen
   • Seppo Ylä-Herttuala

   Leading Article 16 September 2012 Pages: 1575 - 1585

   

2. Single-Agent Immunosuppression After Liver Transplantation

   • Maria L. Raimondo
   • Andrew K. Burroughs

   Leading Article 16 September 2012 Pages: 1587 - 1597

   

3. Cardiovascular Risk Profile of Antirheumatic Agents in Patients with Osteoarthritis and Rheumatoid Arthritis

   • Michael T. Nurmohamed
   • Vokko P. van Halm
   • Ben A. C. Dijkmans

   Therapy in Practice 16 September 2012 Pages: 1599 - 1609

4. Ocular Allergy Guidelines

   • Leonard Bielory

   Therapy in Practice 16 September 2012 Pages: 1611 - 1634

   

5. Generalised Anxiety Disorder

   • John J. Sramek
   • Victoria Zarotsky
   • Neal R. Cutler

   Review Article 16 September 2012 Pages: 1635 - 1648

6. Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death

   • Peter M. Haddad
   • Ian M. Anderson

   Review Article 16 September 2012 Pages: 1649 - 1671

   

7. Fondaparinux Sodium

   • Susan J. Keam
   • Karen L. Goa

   Adis New Drug Profile 16 September 2012 Pages: 1673 - 1685

   

8. Fondaparinux Sodium

   • Alexander G. G. Turpie

   Adis New Drug Profile 16 September 2012 Pages: 1686 - 1686

9. Fondaparinux Sodium

   • Alexander S. Gallus

   Adis New Drug Profile 16 September 2012 Pages: 1686 - 1687

10. Balsalazide

    • Richard B. R. Muijsers
    • Karen L. Goa

    Adis Drug Evaluation 16 September 2012 Pages: 1689 - 1705